Healthcare provider profile · identity verified

Anna Atencio, D.O.

Family Practice · ALTON, TX · NPI 1457791618

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	601	202
Losartan Potassium	Losartan Potassium	359	119
Levothyroxine Sodium	Levothyroxine Sodium	346	108
Diclofenac Sodium	Diclofenac Sodium	244	91
Lisinopril	Lisinopril	244	77
Amlodipine Besylate	Amlodipine Besylate	234	80
Metformin Hcl	Metformin Hcl	226	73
Ozempic	Semaglutide	200	43
Metoprolol Succinate	Metoprolol Succinate	180	59
Omeprazole	Omeprazole	171	65
Montelukast Sodium	Montelukast Sodium	169	67
Tamsulosin Hcl	Tamsulosin Hcl	156	50
Simvastatin	Simvastatin	132	46
Pantoprazole Sodium	Pantoprazole Sodium	122	46
Rosuvastatin Calcium	Rosuvastatin Calcium	119	44
Gabapentin	Gabapentin	108	49
Alendronate Sodium	Alendronate Sodium	106	37
Clonazepam	Clonazepam	101	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	99	33
Donepezil Hcl	Donepezil Hcl	93	36
Fluticasone Propionate	Fluticasone Propionate	92	48
Meclizine Hcl	Meclizine Hcl	90	43
Famotidine	Famotidine	87	29
Trazodone Hcl	Trazodone Hcl	87	30
Glipizide	Glipizide	84	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	84	25
Mounjaro	Tirzepatide	84	21
Sertraline Hcl	Sertraline Hcl	84	27
Zolpidem Tartrate	Zolpidem Tartrate	84	21
Metformin Hcl Er	Metformin Hcl	83	30
Nifedipine Er	Nifedipine	82	29
Jardiance	Empagliflozin	79	19
Farxiga	Dapagliflozin Propanediol	78	21
Hydrochlorothiazide	Hydrochlorothiazide	78	25
Furosemide	Furosemide	68	34
Janumet	Sitagliptin Phos/Metformin Hcl	66	16
Januvia	Sitagliptin Phosphate	64	16
Meloxicam	Meloxicam	59	27
Pioglitazone Hcl	Pioglitazone Hcl	58	22
Azithromycin	Azithromycin	56	52
Ibuprofen	Ibuprofen	56	27
Tramadol Hcl	Tramadol Hcl	56	19
Clopidogrel	Clopidogrel Bisulfate	54	17
Pregabalin	Pregabalin	54	18
Alprazolam	Alprazolam	53	17
Metoprolol Tartrate	Metoprolol Tartrate	53	18
Hydralazine Hcl	Hydralazine Hcl	52	18
Finasteride	Finasteride	50	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	22
Olmesartan Medoxomil	Olmesartan Medoxomil	45	14
Tresiba Flextouch U-100	Insulin Degludec	45	12
Albuterol Sulfate Hfa	Albuterol Sulfate	44	22
Pravastatin Sodium	Pravastatin Sodium	44	14
Mupirocin	Mupirocin	43	25
Escitalopram Oxalate	Escitalopram Oxalate	41	15
Hydroxyzine Hcl	Hydroxyzine Hcl	41	23
Tradjenta	Linagliptin	40	14
Acetaminophen-Codeine	Acetaminophen With Codeine	39	19
Glipizide Er	Glipizide	38	14
Esomeprazole Magnesium	Esomeprazole Magnesium	35	11
Allopurinol	Allopurinol	34	12
Atenolol	Atenolol	34	suppressed
Cefdinir	Cefdinir	34	30
Memantine Hcl	Memantine Hcl	34	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	32	15
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	32	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	32	suppressed
Linzess	Linaclotide	32	16
Fenofibrate	Fenofibrate Nanocrystallized	31	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	27
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	29	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	28	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	27
Potassium Chloride	Potassium Chloride	26	suppressed
Celecoxib	Celecoxib	25	suppressed
Eliquis	Apixaban	25	suppressed
Methylprednisolone	Methylprednisolone	25	21
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	23
Glipizide-Metformin	Glipizide/Metformin Hcl	24	suppressed
Tresiba Flextouch U-200	Insulin Degludec	24	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	21
Ondansetron Hcl	Ondansetron Hcl	23	19
Trulicity	Dulaglutide	23	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	22	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	22	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	21	18
Gemfibrozil	Gemfibrozil	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	21	21
Dicyclomine Hcl	Dicyclomine Hcl	20	16
Entresto	Sacubitril/Valsartan	20	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Carvedilol	Carvedilol	19	12
Mirtazapine	Mirtazapine	18	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	18	suppressed
Amoxicillin	Amoxicillin	17	17
Bumetanide	Bumetanide	17	suppressed
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	17	17
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	17	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Levemir Flexpen	Insulin Detemir	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Terbinafine Hcl	Terbinafine Hcl	15	suppressed
Duloxetine Hcl	Duloxetine Hcl	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Megestrol Acetate	Megestrol Acetate	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Synjardy	Empagliflozin/Metformin Hcl	13	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	13	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	12	suppressed
Creon	Lipase/Protease/Amylase	12	suppressed
Fluconazole	Fluconazole	12	12
Glyxambi	Empagliflozin/Linagliptin	12	suppressed
Lorazepam	Lorazepam	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Valsartan	Valsartan	12	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Metformin Er Osmotic	Metformin Hcl	11	suppressed
Nystatin	Nystatin	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error